DE3825374C2 - - Google Patents

Info

Publication number
DE3825374C2
DE3825374C2 DE3825374A DE3825374A DE3825374C2 DE 3825374 C2 DE3825374 C2 DE 3825374C2 DE 3825374 A DE3825374 A DE 3825374A DE 3825374 A DE3825374 A DE 3825374A DE 3825374 C2 DE3825374 C2 DE 3825374C2
Authority
DE
Germany
Prior art keywords
mitoxantrone
liposomes
novantron
liposome
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3825374A
Other languages
German (de)
English (en)
Other versions
DE3825374A1 (de
Inventor
Reto Dipl.-Apotheker Dr.Sc.Nat. Kilchberg Ch Schwendener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE3825374A priority Critical patent/DE3825374A1/de
Publication of DE3825374A1 publication Critical patent/DE3825374A1/de
Application granted granted Critical
Publication of DE3825374C2 publication Critical patent/DE3825374C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
    • C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
    • C07C225/32—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by at least three rings
    • C07C225/34—Amino anthraquinones
    • C07C225/36—Amino anthraquinones the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3825374A 1988-07-26 1988-07-26 Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren Granted DE3825374A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE3825374A DE3825374A1 (de) 1988-07-26 1988-07-26 Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3825374A DE3825374A1 (de) 1988-07-26 1988-07-26 Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren

Publications (2)

Publication Number Publication Date
DE3825374A1 DE3825374A1 (de) 1990-02-01
DE3825374C2 true DE3825374C2 (enrdf_load_stackoverflow) 1990-06-28

Family

ID=6359585

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3825374A Granted DE3825374A1 (de) 1988-07-26 1988-07-26 Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren

Country Status (1)

Country Link
DE (1) DE3825374A1 (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
US7820193B2 (en) 1993-07-19 2010-10-26 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023241A1 (de) * 1990-07-21 1992-01-23 Knoll Ag Stabile wirkstoff-formulierung
DE4208527A1 (de) * 1992-03-17 1993-09-23 Max Planck Gesellschaft Liposomen mit negativer ueberschussladung
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
EP1674081A1 (de) * 2004-12-23 2006-06-28 KTB Tumorforschungsgesellschaft mbH Herstellung von lipidbasierten Nanopartikeln unter Einsatz einer dualen asymmetrischen Zentrifuge
WO2015013581A1 (en) 2013-07-26 2015-01-29 Update Pharma Inc. Combinatorial methods to improve the therapeutic benefit of bisantrene
WO2019073296A1 (en) * 2017-10-13 2019-04-18 Race Oncology Ltd. LIPOSOMAL FORMULATIONS OF BISANTRENE OR DERIVATIVES OR THE LIKE THEREOF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820193B2 (en) 1993-07-19 2010-10-26 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen

Also Published As

Publication number Publication date
DE3825374A1 (de) 1990-02-01

Similar Documents

Publication Publication Date Title
DE3856550T2 (de) LUV mit gesättigten Phospholipiden und Verfahren zu deren Herstellung
DE69431750T2 (de) Multivesikuläre liposomen mit verkapseltem cyclodextrin und pharmakologisch wirksamen verbindungen sowie verfahren zu deren verwendung
DE69531701T2 (de) Sphingosome mit verbesserter arzneistoffabgage
DE3873528T2 (de) Nystatin enthaltende liposome.
DE69218241T2 (de) Arzneistofformulierung zur parenteralen anwendung
DE60115045T2 (de) Verbesserte liposomale camptothecine und deren verwendungen
DE3785198T2 (de) Liposomes praeparat und antibiotikum.
DE69907243T2 (de) In liposomen eingeschlossene topoisomerase inhibitoren
US5965156A (en) Amphotericin B liposome preparation
DE68901733T2 (de) Liposom-zusammensetzung.
DE3686221T2 (de) Emulsionen zur parenteralen und/oder oralen verabreichung schwer wasserloeslicher ionisierbarer hydrophober arzneistoffe.
DE69837339T2 (de) Veränderung der Wirkstoffladung in multivesikulären Liposomen
DE69530368T2 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
DE69530412T2 (de) Zusammensetzung aus cisplatin in kombination mit 2,2'-dithio-bis(ethansulfonat)(dimesna)
DE69008729T2 (de) Verfahren zur herstellung einer öl-in-wasser-emulsion eines wirkstoffes.
DE69018460T2 (de) Markierung mit liposomen von ischämischen geweben.
DE69432320T2 (de) Fusogene liposomen und verfahren zu deren herstellung und verwendung
DE69326017T2 (de) Antibiotische zubereitung und die verwendung gegen bakterielle infektionen
DE69026820T2 (de) Zubereitung von liposomen- und lipid-komplexzusammensetzungen
DE60222580T2 (de) Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
DE60110057T2 (de) Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung
DE69420859T2 (de) Multilamellare liposomformulierungen, die einen arachidsäuremetaboliten enthalten
DE69117029T2 (de) Verfahren zur herstellung eines durch einbau einer lipophilen wirksubstanz modifizierten lipoproteins
DE3825374C2 (enrdf_load_stackoverflow)
EP0630231B1 (de) Liposomen mit negativer überschussladung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition